Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal Pharma Xplore : Jurnal Sains dan Ilmu Farmasi
Wahyuniarti Wahyuniarti
Prodi Farmasi, Fakultas Ilmu Kesehatan, Universitas Muhammadiyah Ahmad Dahlan Cirebon, Jawa Barat, Indonesia.
Medicine & Pharmacology

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
ANALISIS DRUG RELATED PROBLEMS (DRPs) DOMAIN PEMILIHAN DOSIS ANTIDIABETES ORAL PASIEN DIABETES MELITUS TIPE 2 DI RSUD KABUPATEN MAJALENGKA TAHUN 2024 Wahyuniarti Wahyuniarti; Like Efriani; Ismanurrahman Hadi
Pharma Xplore : Jurnal Sains dan Ilmu Farmasi Vol 10 No 2 (2025): Pharma Xplore : Jurnal Sains dan Ilmu Farmasi
Publisher : Fakultas Farmasi Universitas Buana Perjuangan Karawang

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36805/wz9pm239

Abstract

Type 2 diabetes mellitus (DM) is a chronic disease that requires continuous drug therapy. In the use of oral antidiabetic drugs, type 2 DM patients are prone to errors due to suboptimal drug use in terms of both dosage and frequency. These medication errors are referred to as Drug-Related Problems (DRPs). This study aims to determine patient characteristics, patterns of oral antidiabetic prescription, and analyze DRPs related to the selection of oral antidiabetic doses in type 2 DM patients at Majalengka Regional General Hospital. This study is a retrospective observational study with a cross-sectional approach, using data from 85 outpatient medical records that met the inclusion criteria, namely type 2 DM patients with comorbid hypertension who received oral antidiabetic therapy during the period January-December 2024. The results indicated that most patients received combination therapy with two oral antidiabetic drugs (52%). One case (1.17%) of DRPs was found in the category of metformin overdose, which has the potential to cause drug toxicity in the form of lactic acidosis. These findings indicate that although DRP cases are relatively low, monitoring drug use in the form of medication reviews is still necessary as a preventive measure against DRPs.
Co-Authors Ismanurrahman Hadi Like Efriani